Boundless Bio GAAP EPS of -$0.60
Source: SeekingAlpha
2026-05-08 07:35:09 ET
More on Boundless Bio
- Boundless Bio: An Underestimated Biotech With A First-In-Class EcDNA Targeted Kinesin Degrader
- Seeking Alpha’s Quant Rating on Boundless Bio
- Historical earnings data for Boundless Bio
- Financial information for Boundless Bio
Read the full article on Seeking Alpha
For further details see:
Boundless Bio GAAP EPS of -$0.60
Boundless Bio Inc.
NASDAQ: BOLD
BOLD Trading
-2.07% G/L:
$1.42 Last:
13,631 Volume:
$1.49 Open:
BOLD Latest News
May 08, 2026 07:00:00 am
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
BOLD Stock Data
$25,819,564
17,662,247
6.34%
6
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
